Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2018, Cilt: 48 Sayı: 3, 63 - 67, 01.12.2018

Öz

Kaynakça

  • • Cetin I, Topcul MR (2017). In vitro antiproliferative effects of nab-paclitaxel with liposomal cisplatin on MDA-MB-231 and MCF-7 breast cancer cell lines. J BUON 22: 347-354.
  • • Eldehna WM, Altoukhy A, Mahrous H, Abdel-Aziz HA (2015). Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. Eur J Med Chem 90: 684-694.
  • • Gabr MT, El-Gohary NS, El-Bendary ER, El-Kerdawy MM, Ni N (2017). Isatin-β-thiocarbohydrazones: Microwave-assisted synthesis, antitumor activity and structure-activity relationship. Eur J Med Chem 128: 36-44.
  • • Hall MD, Salam NK, Hellawell JL, Fales HM, Kensler CB, Ludwig JA, Szakács G, Hibbs DE, Gottesman MM (2009). Synthesis, activity, and pharmacophore development for isatin-β-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem 52: 3191-3204.
  • • Karalı N, Gürsoy A, Kandemirli F, Shvets N, Kaynak FB, Özbey S, Kovalishyn V, Dimoglo A (2007). Synthesis and structure antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 15: 5888-5904.
  • • Karalı N, Akdemir A, Göktaş F, Eraslan Elma P, Angeli A, Kızılırmak M, Supuran CT (2017). Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrazes, Bioorg Med Chem 25: 3714-3718.
  • • Liu W, Zhu HM, Niu GJ, Shi, EZ, Chen J, Sun B, Chen WQ, Zhou HG, Yang C (2014). Synthesis, modification and docking studies of 5-sulfonylisatin derivatives as SARS-CoV 3C-like protease inhibitors. Bioorg Med Chem 22: 292-302.
  • • Lv K, Wang LL, Liu ML, Zhou XB, Fan SY, Liu HY, Zheng ZB, Li S (2011). Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides. Bioorg Med Chem Lett 21: 3062-3065.
  • • Pakravan P, Kashanian S, Khodaei MM, Harding FJ (2013). Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity. Pharmacol Rep 65: 313-335.
  • • Pape VFS, Tóth S, Füredi A, Szebényi K, Lovrics A, Szabó P, Wiese M, Szakács G (2016). Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Eur J Med Chem, 117: 335-354.
  • • Patel A, Bari S, Talele G, Patel J, Sarangapani M (2006). Synthesis and antimicrobial activity of some new isatin derivatives. Iran J Pharm Res 4: 249-254.
  • • Remesh A (2012). Toxicities of anticancer drugs and its management. Int J Basic Clin Pharmacol 1: 2-12.
  • • Sarkar FH, Li Y (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66: 3347-3350.
  • • Singh A, Raghuwanshi K, Patel VK, Jain DK, Veerasamy R, Dixit A, Rajak H (2017). Assessment of 5-substituted isatin as surface recognition group: Design, synthesis, and antiproliferative evaluation of hydroxamates as novel histone deacetylase inhibitors. Pharm. Chem. J 51: 366-374.
  • • Topcul MR, Cetin I, Kolusayın Ozar MO (2013). The effects of anastrozole on the proliferation of Fm3a cells. J BUON 18: 874-878.
  • • Vine KL, Matesic L, Locke JM, Ranson M, Skropeta D (2009). Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008. Anticancer Agents Med Chem 9: 397-414.
  • • World Health Organization, http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed February 2018.
  • • Zhou L, Liu Y, Zhang W, Wei P, Huang C, Pei J, Yuan Y, Lai L (2006). Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. J Med Chem 49: 3440-3443.

Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives

Yıl 2018, Cilt: 48 Sayı: 3, 63 - 67, 01.12.2018

Öz

DOI: 10.26650/IstanbulJPharm.2018.414805


In this study, the cytotoxic effects of
1H-indole-2,3-dione 3-[N-(4-sulfamoylphenyl)thiosemicarbazone derivatives
namely, 4a-d were evaluated using cell kinetic parameters including the cell
index, mitotic index, labelling index and apoptotic index on HeLa cells taken
from a human cervix carcinoma. All compounds were evaluated using cell index
parameters at 5, 10, 20, 40, 80, 100 and 160 μM concentrations. As a result of
this, it was seen that all 4a-d compounds were effective in different
concentrations. Different cell death mechanisms were proposed for 4a-d. When
all the parameters were examined, it was found that the bromine substituted 4c
was the most potent antiproliferative compound in the tested compounds. The
difference was significant between the control and experimental groups
(p<0.01). In addition, a statistically significant difference was noted
among all experimental groups (p<0.01).


Kaynakça

  • • Cetin I, Topcul MR (2017). In vitro antiproliferative effects of nab-paclitaxel with liposomal cisplatin on MDA-MB-231 and MCF-7 breast cancer cell lines. J BUON 22: 347-354.
  • • Eldehna WM, Altoukhy A, Mahrous H, Abdel-Aziz HA (2015). Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. Eur J Med Chem 90: 684-694.
  • • Gabr MT, El-Gohary NS, El-Bendary ER, El-Kerdawy MM, Ni N (2017). Isatin-β-thiocarbohydrazones: Microwave-assisted synthesis, antitumor activity and structure-activity relationship. Eur J Med Chem 128: 36-44.
  • • Hall MD, Salam NK, Hellawell JL, Fales HM, Kensler CB, Ludwig JA, Szakács G, Hibbs DE, Gottesman MM (2009). Synthesis, activity, and pharmacophore development for isatin-β-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem 52: 3191-3204.
  • • Karalı N, Gürsoy A, Kandemirli F, Shvets N, Kaynak FB, Özbey S, Kovalishyn V, Dimoglo A (2007). Synthesis and structure antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 15: 5888-5904.
  • • Karalı N, Akdemir A, Göktaş F, Eraslan Elma P, Angeli A, Kızılırmak M, Supuran CT (2017). Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrazes, Bioorg Med Chem 25: 3714-3718.
  • • Liu W, Zhu HM, Niu GJ, Shi, EZ, Chen J, Sun B, Chen WQ, Zhou HG, Yang C (2014). Synthesis, modification and docking studies of 5-sulfonylisatin derivatives as SARS-CoV 3C-like protease inhibitors. Bioorg Med Chem 22: 292-302.
  • • Lv K, Wang LL, Liu ML, Zhou XB, Fan SY, Liu HY, Zheng ZB, Li S (2011). Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides. Bioorg Med Chem Lett 21: 3062-3065.
  • • Pakravan P, Kashanian S, Khodaei MM, Harding FJ (2013). Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity. Pharmacol Rep 65: 313-335.
  • • Pape VFS, Tóth S, Füredi A, Szebényi K, Lovrics A, Szabó P, Wiese M, Szakács G (2016). Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Eur J Med Chem, 117: 335-354.
  • • Patel A, Bari S, Talele G, Patel J, Sarangapani M (2006). Synthesis and antimicrobial activity of some new isatin derivatives. Iran J Pharm Res 4: 249-254.
  • • Remesh A (2012). Toxicities of anticancer drugs and its management. Int J Basic Clin Pharmacol 1: 2-12.
  • • Sarkar FH, Li Y (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66: 3347-3350.
  • • Singh A, Raghuwanshi K, Patel VK, Jain DK, Veerasamy R, Dixit A, Rajak H (2017). Assessment of 5-substituted isatin as surface recognition group: Design, synthesis, and antiproliferative evaluation of hydroxamates as novel histone deacetylase inhibitors. Pharm. Chem. J 51: 366-374.
  • • Topcul MR, Cetin I, Kolusayın Ozar MO (2013). The effects of anastrozole on the proliferation of Fm3a cells. J BUON 18: 874-878.
  • • Vine KL, Matesic L, Locke JM, Ranson M, Skropeta D (2009). Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008. Anticancer Agents Med Chem 9: 397-414.
  • • World Health Organization, http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed February 2018.
  • • Zhou L, Liu Y, Zhang W, Wei P, Huang C, Pei J, Yuan Y, Lai L (2006). Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. J Med Chem 49: 3440-3443.
Toplam 18 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Eczacılık ve İlaç Bilimleri
Bölüm Original Article
Yazarlar

İdil Çetin

Pınar Eraslan Elma Bu kişi benim

Mehmet Topçul

Nilgün Karalı

Yayımlanma Tarihi 1 Aralık 2018
Gönderilme Tarihi 12 Nisan 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 48 Sayı: 3

Kaynak Göster

APA Çetin, İ., Eraslan Elma, P., Topçul, M., Karalı, N. (2018). Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives. İstanbul Journal of Pharmacy, 48(3), 63-67.
AMA Çetin İ, Eraslan Elma P, Topçul M, Karalı N. Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives. iujp. Aralık 2018;48(3):63-67.
Chicago Çetin, İdil, Pınar Eraslan Elma, Mehmet Topçul, ve Nilgün Karalı. “Anticancer Activities and Cell Death Mechanisms of 1H-Indole-2,3-Dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] Derivatives”. İstanbul Journal of Pharmacy 48, sy. 3 (Aralık 2018): 63-67.
EndNote Çetin İ, Eraslan Elma P, Topçul M, Karalı N (01 Aralık 2018) Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives. İstanbul Journal of Pharmacy 48 3 63–67.
IEEE İ. Çetin, P. Eraslan Elma, M. Topçul, ve N. Karalı, “Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives”, iujp, c. 48, sy. 3, ss. 63–67, 2018.
ISNAD Çetin, İdil vd. “Anticancer Activities and Cell Death Mechanisms of 1H-Indole-2,3-Dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] Derivatives”. İstanbul Journal of Pharmacy 48/3 (Aralık 2018), 63-67.
JAMA Çetin İ, Eraslan Elma P, Topçul M, Karalı N. Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives. iujp. 2018;48:63–67.
MLA Çetin, İdil vd. “Anticancer Activities and Cell Death Mechanisms of 1H-Indole-2,3-Dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] Derivatives”. İstanbul Journal of Pharmacy, c. 48, sy. 3, 2018, ss. 63-67.
Vancouver Çetin İ, Eraslan Elma P, Topçul M, Karalı N. Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives. iujp. 2018;48(3):63-7.